ArticleAmerican journal of cancer research2025

Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis.

Lori A Leslie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.